HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Study sponsor: Soligenix
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-05-31Actual
Enrollment · participants10Actual
Source updated2025-08-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.